Drug Shortage Report for LINEZOLID INJECTION
Report ID | 159027 |
Drug Identification Number | 02430827 |
Brand name | LINEZOLID INJECTION |
Common or Proper name | LINEZOLID INJECTION |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | LINEZOLID |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 300 mL |
ATC code | J01XX |
ATC description | OTHER ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-04-30 |
Estimated end date | 2022-06-24 |
Actual end date | 2022-06-24 |
Shortage status | Resolved |
Updated date | 2022-06-27 |
Company comments | Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Linezolid Injection 2 mg/mL freeflex® Bag 300 mL effective April 30, 2022 until June 24, 2022. Please note that all available inventory expires April 30, 2022. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-06-27 | French | Compare |
v8 | 2022-06-27 | English | Compare |
v7 | 2022-06-08 | French | Compare |
v6 | 2022-06-08 | English | Compare |
v5 | 2022-05-30 | French | Compare |
v4 | 2022-05-30 | English | Compare |
v3 | 2022-05-01 | English | Compare |
v2 | 2022-04-20 | French | Compare |
v1 | 2022-04-20 | English | Compare |
Showing 1 to 9 of 9